Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henit Yanai

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Journal of Crohn'S & Colitis|December 12, 2018
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre StudyHenit Yanai, Iris Dotan
Alimentary Pharmacology & Therapeutics|December 31, 2021
Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?Idan Goren, Henit Yanai
The American Journal of Gastroenterology|March 24, 2011
Assessing response and loss of response to biological therapies in IBDHenit Yanai, Stephen B Hanauer
Journal of Crohn'S & Colitis|April 20, 2024
Navigating Postoperative Management in Crohn's Disease: Insights from the PORCSE StudyJacob E Ollech, Henit Yanai
European Journal of Gastroenterology & Hepatology|June 17, 2016
Impact of demographic and clinical parameters on video capsule transit timeEva Niv, Hadassa Pinchasovich, Henit Yanai
Current Gastroenterology Reports|October 18, 2016
Complementary Therapies in Inflammatory Bowel DiseasesHenit Yanai, Nir Salomon, Adi Lahat
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2020
ReplyHenit Yanai, Idan Goren, Iris Dotan
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: 5-aminosalicylate maintenance treatment in mild Crohn's disease-authors' replyOhad Atia, Idan Goren, Henit Yanai
Alimentary Pharmacology & Therapeutics|August 26, 2023
Letter: Chinese herbal medicine Curcumin-QingDai (CurQD)-A good treatment option for active ulcerative colitis? Authors' replyHenit Yanai, Nir Salomon, Shomron Ben-Horin, et al.
Journal of Crohn'S & Colitis|September 16, 2024
Letter: Change in Bowel Urgency in Active Ulcerative Colitis Patients Treated with Curcumin-QingDai (CurQD): A Post Hoc Analysis of a Randomized Placebo-Controlled TrialShomron Ben-Horin, Nir Salomon, Henit Yanai, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Journal of Crohn'S & Colitis|December 12, 2018
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre StudyHenit Yanai, Iris Dotan
Alimentary Pharmacology & Therapeutics|December 31, 2021
Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?Idan Goren, Henit Yanai
The American Journal of Gastroenterology|March 24, 2011
Assessing response and loss of response to biological therapies in IBDHenit Yanai, Stephen B Hanauer
Journal of Crohn'S & Colitis|April 20, 2024
Navigating Postoperative Management in Crohn's Disease: Insights from the PORCSE StudyJacob E Ollech, Henit Yanai
European Journal of Gastroenterology & Hepatology|June 17, 2016
Impact of demographic and clinical parameters on video capsule transit timeEva Niv, Hadassa Pinchasovich, Henit Yanai
Current Gastroenterology Reports|October 18, 2016
Complementary Therapies in Inflammatory Bowel DiseasesHenit Yanai, Nir Salomon, Adi Lahat
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2020
ReplyHenit Yanai, Idan Goren, Iris Dotan
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: 5-aminosalicylate maintenance treatment in mild Crohn's disease-authors' replyOhad Atia, Idan Goren, Henit Yanai
Alimentary Pharmacology & Therapeutics|August 26, 2023
Letter: Chinese herbal medicine Curcumin-QingDai (CurQD)-A good treatment option for active ulcerative colitis? Authors' replyHenit Yanai, Nir Salomon, Shomron Ben-Horin, et al.
Journal of Crohn'S & Colitis|September 16, 2024
Letter: Change in Bowel Urgency in Active Ulcerative Colitis Patients Treated with Curcumin-QingDai (CurQD): A Post Hoc Analysis of a Randomized Placebo-Controlled TrialShomron Ben-Horin, Nir Salomon, Henit Yanai, et al.
Pageof 13